Stemtech Corp (STEK)
About Stemtech Corp
STEMTECH CORP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.9M
- Net income
- -$4.0M
- Total assets
- $3.1M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Stemtech Corp (STEK) Stock Price
- Reported a net loss of $4.0M in FY2025.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Stemtech Corp.
Write a review
Stemtech Corp: frequently asked questions
Is Stemtech Corp an American company?
Stemtech Corp is a US-based company headquartered in Naples, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Stemtech Corp headquartered?
Stemtech Corp is headquartered in Naples, Florida, United States.
Is Stemtech Corp publicly traded?
Yes — Stemtech Corp is a publicly traded company. Its stock trades under the ticker symbol STEK on the OTC.
What does Stemtech Corp do?
Stemtech Corp is an American Pharmaceuticals company in the Health & Beauty sector.
